These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17786295)

  • 1. Suppression of hepatocyte growth factor activator inhibitor-1 leads to a more aggressive phenotype of prostate cancer cells in vitro.
    Sanders AJ; Parr C; Mason MD; Jiang WG
    Int J Mol Med; 2007 Oct; 20(4):613-9. PubMed ID: 17786295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells.
    Parr C; Jiang WG
    Int J Cancer; 2006 Sep; 119(5):1176-83. PubMed ID: 16557597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro inhibition of matriptase prevents invasive growth of cell lines of prostate and colon carcinoma.
    Förbs D; Thiel S; Stella MC; Stürzebecher A; Schweinitz A; Steinmetzer T; Stürzebecher J; Uhland K
    Int J Oncol; 2005 Oct; 27(4):1061-70. PubMed ID: 16142324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1.
    Saleem M; Adhami VM; Zhong W; Longley BJ; Lin CY; Dickson RB; Reagan-Shaw S; Jarrard DF; Mukhtar H
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):217-27. PubMed ID: 16492908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein expression of matriptase and its cognate inhibitor HAI-1 in human prostate cancer: a tissue microarray and automated quantitative analysis.
    Warren M; Twohig M; Pier T; Eickhoff J; Lin CY; Jarrard D; Huang W
    Appl Immunohistochem Mol Morphol; 2009 Jan; 17(1):23-30. PubMed ID: 18813126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hepatocyte growth factor on invasion of prostate cancer cell lines.
    Fujiuchi Y; Nagakawa O; Murakami K; Fuse H; Saiki I
    Oncol Rep; 2003; 10(4):1001-6. PubMed ID: 12792760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of membrane-bound serine protease inhibitor HAI-1 induces oral squamous cell carcinoma cells' invasiveness.
    Baba T; Kawaguchi M; Fukushima T; Sato Y; Orikawa H; Yorita K; Tanaka H; Lin CY; Sakoda S; Kataoka H
    J Pathol; 2012 Oct; 228(2):181-92. PubMed ID: 22262311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic reduction of matriptase-1 expression is associated with a reduction in the aggressive phenotype of prostate cancer cells in vitro and in vivo.
    Sanders AJ; Parr C; Davies G; Martin TA; Lane J; Mason MD; Jiang WG
    J Exp Ther Oncol; 2006; 6(1):39-48. PubMed ID: 17228523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of HAI-1 over-expression on in vitro growth and migration/motility of SW620 cells].
    Cao J; Ye JJ
    Shi Yan Sheng Wu Xue Bao; 2005 Jun; 38(3):183-9. PubMed ID: 16044910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-Cl-AHPC inhibits pro-HGF maturation by inducing matriptase/HAI-1 complex formation.
    Ye F; Chen S; Liu X; Ye X; Wang K; Zeng Z; Su Y; Zhang XK; Zhou H
    J Cell Mol Med; 2019 Jan; 23(1):155-166. PubMed ID: 30370662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospholipase-C gamma-1 (PLCgamma-1) is critical in hepatocyte growth factor induced in vitro invasion and migration without affecting the growth of prostate cancer cells.
    Davies G; Martin TA; Ye L; Lewis-Russell JM; Mason MD; Jiang WG
    Urol Oncol; 2008; 26(4):386-91. PubMed ID: 18367108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of hepatocyte activator inhibitor-1 expression by androgen and oncogenic transformation in the prostate.
    Knudsen BS; Lucas JM; Fazli L; Hawley S; Falcon S; Coleman IM; Martin DB; Xu C; True LD; Gleave ME; Nelson PS; Ayala GE
    Am J Pathol; 2005 Jul; 167(1):255-66. PubMed ID: 15972969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Hepatocyte growth factor activator inhibitor type-1 (HAI-1) in prostate cancer.
    Yasuda K; Komiya A; Watanabe A; Morii A; Oya T; Nagakawa O; Fujiuchi Y; Fuse H
    Anticancer Res; 2013 Feb; 33(2):575-81. PubMed ID: 23393351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the HGF/SF receptor c-met using a hammerhead ribozyme transgene reduces in vitro invasion and migration in prostate cancer cells.
    Davies G; Watkins G; Mason MD; Jiang WG
    Prostate; 2004 Sep; 60(4):317-24. PubMed ID: 15264243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro-hepatocyte growth factor.
    Hashimoto T; Kato M; Shimomura T; Kitamura N
    FEBS J; 2010 Dec; 277(23):4888-900. PubMed ID: 20977675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2.
    Kirchhofer D; Peek M; Lipari MT; Billeci K; Fan B; Moran P
    FEBS Lett; 2005 Mar; 579(9):1945-50. PubMed ID: 15792801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model.
    Ye J; Kawaguchi M; Haruyama Y; Kanemaru A; Fukushima T; Yamamoto K; Lin CY; Kataoka H
    Cancer Sci; 2014 Jan; 105(1):44-51. PubMed ID: 24147538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro evidence that KLK14 regulates the components of the HGF/Met axis, pro-HGF and HGF-activator inhibitor 1A and 1B.
    Reid JC; Bennett NC; Stephens CR; Carroll ML; Magdolen V; Clements JA; Hooper JD
    Biol Chem; 2016 Dec; 397(12):1299-1305. PubMed ID: 27533117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells.
    Wu SR; Teng CH; Tu YT; Ko CJ; Cheng TS; Lan SW; Lin HY; Lin HH; Tu HF; Hsiao PW; Huang HP; Chen CH; Lee MS
    Sci Rep; 2017 Nov; 7(1):15101. PubMed ID: 29118397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
    Kataoka H; Hamasuna R; Itoh H; Kitamura N; Koono M
    Cancer Res; 2000 Nov; 60(21):6148-59. PubMed ID: 11085539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.